Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features.
OBJECTIVE
Oxidative stress may be one of the important complex pathogenetic mechanisms that lead to damage in scleroderma; free radicals may provoke endothelial injury, fibroblast proliferation and fragmentation of autoantigens favouring induction of autoantibodies. The present study investigates the oxidant status in scleroderma patients by measuring the urinary concentration of 8-isoprostaglandin-F2alpha, an F2-isoprostane, and a product of free radical-mediated peroxidation of arachidonic acid.


METHODS
Forty-three scleroderma patients (42 women and 1 man, mean age 54.1 yr, mean disease duration 9.0 yr) underwent clinical evaluation and instrumental investigations in order to assess skin, vascular, lung and heart involvement. Von Willebrand factor was evaluated as marker of vascular dysfunction in 36 out of the 43 cases. The urinary level of 8-isoprostaglandin-F2alpha was measured in all scleroderma patients and in the 43 age- and sex-matched healthy controls.


RESULTS
Urinary levels of 8-isoprostaglandin-F2alpha were higher in scleroderma patients than in the healthy control group (341.7 vs 147.6 pg/mg creatinine; P < 0.001). Values of 8-isoprostaglandin-F2alpha were strongly correlated with the nailfold videocapillaroscopy pattern and lung involvement (P = 0.002 and 0.003, respectively), showing increasing levels with the progression of pulmonary severity. Correlation between 8-isoprostaglandin-F2alpha level and von Willebrand factor narrowly failed to reach statistical significance (P = 0.05). There was no correlation between 8-isoprostaglandin-F2alpha concentration and disease activity, vascular, skin and heart involvement, disease pattern or autoantibody profile.


CONCLUSIONS
Our study further supports the role of oxidant stress in the pathogenesis of scleroderma, showing a strong correlation between a marker of free radical damage with both the severity of lung involvement and the videocapillaroscopic patterns.
Volpe
A
A
Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona,Verona, Italy.
Biasi
D
D
Caramaschi
P
P
Mantovani
W
W
Bambara
L M
LM
Canestrini
S
S
Ferrari
M
M
Poli
G
G
Degan
M
M
Carletto
A
A
Pieropan
S
S
Minuz
P
P
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000652:urine; D002196:Capillaries / Q000473:pathology; D018450:Disease Progression; D028441:F2-Isoprostanes / Q000652:urine*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000652:urine; D008297:Male; D020678:Microscopic Angioscopy; D008875:Middle Aged; D009262:Nails / Q000098:blood supply; D018384:Oxidative Stress; D012595:Scleroderma, Systemic / Q000150:complications / Q000503:physiopathology / Q000652:urine*; D012720:Severity of Illness Index; D014841:von Willebrand Factor / Q000032:analysis
D015415:Biomarkers; D028441:F2-Isoprostanes; D014841:von Willebrand Factor